Comparative optimism can be defined as a self-serving, asymmetric judgment of the future. It is often thought to be beneficial and socially accepted, whereas comparative pessimism is correlated with depression and socially rejected. Our goal was to examine the social acceptance of comparative optimism and the social rejection of comparative pessimism in two dimensions of social judgment, social desirability and social utility, considering the attributions of dysphoria and risk-taking potential (studies 2 and 3) on outlooks on the future. In three experiments, the participants assessed either one (study 1) or several (studies 2 and 3) fictional targets in two dimensions, social utility and social desirability. Targets exhibiting comparatively optimistic or pessimistic outlooks on the future were presented as non-depressed, depressed, or neither (control condition) (study 1); non-depressed or depressed (study 2); and non-depressed or in control condition (study 3). Two significant results were obtained: (1) social rejection of comparative pessimism in the social desirability dimension, which can be explained by its depressive feature; and (2) comparative optimism was socially accepted on the social utility dimension, which can be explained by the perception that comparatively optimistic individuals are potential risk-takers.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1017/sjp.2015.9 | DOI Listing |
Eur Ann Allergy Clin Immunol
January 2025
Department of Allergy and Clinical Immunology, New Civil Hospital of Guadalajara "Dr. Juan I. Menchaca", Colonia La Perla, Guadalajara, Jalisco, México.
It has been observed that diseases such as rhinitis and asthma not only affect the physical health of individuals but can also significantly impact their psychological well-being. The aim of this study is to analyze the relationship between allergic rhinitis (AR), non-allergic rhinitis (NAR), and asthma with symptoms of depression in adults. Comparative cross-sectional study.
View Article and Find Full Text PDFBMC Psychiatry
November 2024
Faculty of Social Sciences, Chongqing University, Shapingba, Chongqing, 400044, China.
Background: Previous research has identified a positive relationship between problematic social media use and depression. However, with the increasing diversification and personalization of social media platforms, the impact of different platforms on college students varies significantly. It is necessary to examine the specific symptom network of problematic use in certain platforms and its relationship with depression.
View Article and Find Full Text PDFERJ Open Res
November 2024
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Introduction: Exacerbation of COPD complicated by respiratory acidaemia is the commonest indication for noninvasive ventilation (NIV). The NIV outcomes (NIVO) score offers the best estimate of survival for those ventilated. Unfortunately, two-thirds of cases of COPD are unrecognised, and patients may present without COPD having been confirmed by spirometry.
View Article and Find Full Text PDFCogn Emot
November 2024
Faculty of Arts and Social Sciences, Sabanci University, Istanbul, Turkey.
Individuals high in depressive symptom severity show probability bias: they believe negative events are relatively probable, and positive events relatively improbable, compared to those with less severe symptoms. However, this has only ever been demonstrated using self-report measures, in which participants explicitly estimate events' probabilities: this leaves open the risk that "probability bias" is merely an artefact of response bias. We tested the veracity of probability bias using an indirect behavioural measure, based on a sentence-reading task.
View Article and Find Full Text PDFPLoS One
October 2024
Institute for Complementary and Integrative Medicine, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Introduction: A patient's perceived sensitivity to medicines (PSM) might influence the reported side effects of a treatment. The experience of side effects can result in personal and structural costs (such as nonadherence). Research on nocebo mechanisms and the workings of side effect reporting has been disproportionally smaller compared to the emerging evidence of the individual and clinical impact of the matter.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!